PROG Projected Dividend Yield
Progenity Inc ( NASDAQ : PROG )Progenity is a biotechnology company. Co. supports patients and physicians during patients' life decisions with its suite of molecular tests, including: Innatal Prenatal Screen, which is a noninvasive prenatal test provided to women early in pregnancy to screen for risk of fetal chromosomal conditions, such as Down syndrome and sex chromosome disorders; and Resura Prenatal Test for Monogenic Disease, which is a test for monogenic diseases. Co.'s precision medicine development pipeline includes Recoverable Sampling System, which is an ingestible capsule platform designed to enable the collection, preservation, and analysis of samples from previously inaccessible parts of the small intestine. 21 YEAR PERFORMANCE RESULTS |
PROG Dividend History Detail PROG Dividend News PROG Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |